Since collated evidence confirms the roles of cytokines such as TNF-α in the promotion of insulin resistance by the generation of ROS or the activation of JNK in inflammatory pathway signaling, the inhibition of JNK could be an important target for the treatment of inflammation-induced insulin resistance or abnormal glucose tolerance in obesity [133,134]. This evidence concerns the gene MAPK8 and Insulin resistance.